De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Hikma Pharmaceuticals Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Hikma Pharmaceuticals heeft een totaal eigen vermogen van $2.3B en een totale schuld van $1.2B, wat de schuld-eigenvermogensverhouding op 53.2% brengt. De totale activa en totale passiva bedragen respectievelijk $4.8B en $2.5B. De EBIT Hikma Pharmaceuticals is $712.0M waardoor de rentedekking 11 is. Het heeft contanten en kortetermijnbeleggingen van $260.0M.
Belangrijke informatie
53.2%
Verhouding schuld/eigen vermogen
US$1.22b
Schuld
| Rente dekkingsratio | 11x |
| Contant | US$260.00m |
| Aandelen | US$2.30b |
| Totaal verplichtingen | US$2.55b |
| Totaal activa | US$4.85b |
Recente financiële gezondheidsupdates
Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Apr 02
Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Dec 27Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Sep 19Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Jun 21Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Mar 14Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Sep 27Recent updates
Hikma Pharmaceuticals PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Aug 11Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 36% Below Their Intrinsic Value Estimate
Aug 01Is Hikma Pharmaceuticals PLC (LON:HIK) Trading At A 29% Discount?
Apr 24Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Apr 02Hikma Pharmaceuticals PLC's (LON:HIK) Share Price Matching Investor Opinion
Feb 25Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Dec 27An Intrinsic Calculation For Hikma Pharmaceuticals PLC (LON:HIK) Suggests It's 43% Undervalued
Dec 12Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Sep 19Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Sep 01Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Jun 21Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 28% Above Its Share Price
Jun 02Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Mar 14Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Feb 21Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Sep 27Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 24These 4 Measures Indicate That Hikma Pharmaceuticals (LON:HIK) Is Using Debt Reasonably Well
Jun 06Here's Why Hikma Pharmaceuticals (LON:HIK) Can Manage Its Debt Responsibly
Feb 26Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 92% Above Its Share Price
Dec 01Is Hikma Pharmaceuticals (LON:HIK) Using Too Much Debt?
Nov 11Is There An Opportunity With Hikma Pharmaceuticals PLC's (LON:HIK) 32% Undervaluation?
Sep 02Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Aug 09Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 26% Below Their Intrinsic Value Estimate
May 21Hikma Pharmaceuticals (LON:HIK) Seems To Use Debt Quite Sensibly
May 03It's Unlikely That Hikma Pharmaceuticals PLC's (LON:HIK) CEO Will See A Huge Pay Rise This Year
Apr 16How Does Hikma Pharmaceuticals PLC (LON:HIK) Stand Up To These Simple Dividend Safety Checks?
Apr 13Hikma Pharmaceuticals PLC (LON:HIK) Looks Interesting, And It's About To Pay A Dividend
Mar 14Hikma Pharmaceuticals PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 28Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $2.3B ) HIK } overtreffen de korte termijn passiva ( $1.4B ).
Langlopende schulden: De kortetermijnactiva HIK ( $2.3B ) overtreffen de langetermijnschulden ( $1.2B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 41.9% ) HIK wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van HIK is de afgelopen 5 jaar gestegen van 34.1% naar 53.2%.
Schuldendekking: De schuld van HIK wordt goed gedekt door de operationele kasstroom ( 47.8% ).
Rentedekking: De rentebetalingen op de schuld van HIK worden goed gedekt door EBIT ( 11 x dekking).